Items where Author is "Hancock, BW"

Journal article

RODGERS, S., REES, R.C. and HANCOCK, B.W., 1994. Changes in the Phenotypic Characteristics of Eosinophils from Patients Receiving Recombinant Human Interleukin-2 (Rhil-2) Therapy. British Journal of Haematology, 86 (4), pp. 746-753. ISSN 0007-1048

PLATTS, K.E., LAWRY, J., HANCOCK, B.W. and REES, R.C., 1993. Phenotypic and Cell-Cycle Analysis of Human Peripheral-Blood Mononuclear-Cells Activated with Interleukin-2 and Or Okt3. Experimental Cell Research, 208 (1), pp. 154-160. ISSN 0014-4827

CARTER, C.R.D., HANCOCK, B.W. and REES, R.C., 1992. The Augmentation of Lymphokine-Activated Killer Activity Following Pulsing of Human Peripheral-Blood Mononuclear-Cells with Recombinant Human Interleukin-2. Cancer Immunology Immunotherapy, 35 (4), pp. 264-270. ISSN 0340-7004

MCINTYRE, C.A., CHAPMAN, K., REEDER, S., DORREEN, M.S., BRUCE, L., RODGERS, S., HAYAT, K., SCHREENIVASAN, T., SHERIDAN, E., HANCOCK, B.W. and REES, R.C., 1992. Treatment of Malignant-Melanoma and Renal-Cell Carcinoma with Recombinant Human Interleukin-2 - Analysis of Cytokine Levels in Sera and Culture Supernatants. European Journal of Cancer, 28 (1), pp. 58-63. ISSN 0959-8049

HAYAT, K., FINNEGAN, M., LEE, K.A., REES, R.C., HANCOCK, B.W. and GOYNS, M.H., 1992. Variable Expression of the Interleukin-2 Receptor Alpha-Chain and Myc Genes in Lymphocytes from Renal-Cell Carcinoma Patients Treated with Interleukin-2. Cancer Letters, 65 (2), pp. 173-178. ISSN 0304-3835

DORREEN, M.S., SHERIDAN, E., SREENIVASAN, T., HAYAT, K., ROGERS, S., BRUCE, L., HANCOCK, B.W., CHAPMAN, K. and REES, R.C., 1991. Clinical and Biological Responses Following Interleukin-2 Therapy in Patients with Metastatic Melanoma and Renal-Cell Carcinoma. British Journal of Cancer, 63 (5), pp. 833-834. ISSN 0007-0920

HANCOCK, B.W. and REES, R.C., 1990. Interleukin-2 and Cancer-Therapy. Cancer Cells-A Monthly Review, 2 (1), pp. 29-32. ISSN 1042-2196

HAWRYLOWICZ, C.M., REES, R.C., POTTER, C.W. and HANCOCK, B.W., 1982. Altered natural killer cell response in patients with malignant lymphoma. Philosophical Transactions of the Royal Society of London, 299, pp. 141-144.

HAWRYLOWICZ, C.M., REES, R.C., HANCOCK, B.W. and POTTER, C.W., 1982. Depressed natural killer cell activity in patients with malignant lymphoma and failure of NK cells to respond to interferon treatment in vitro. European Journal of Cancer & Clinical Oncology, 18, pp. 1081-1088.

KADHIM, S., REES, R.C., POTTER, C.W., WALKER, J.R. and HANCOCK, B.W., 1981. Studies on the high-and-low affinity rosette forming T-Iymphocytes in patients with Hodgkin's and non-Hodgkin's lymphoma. European Journal of Cancer, 17, pp. 569-575.